← FDA Drug Approvals (Drugs@FDA)

SIMVASTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2014-11-25

Drug application

FDA Application #

ANDA200895

Application type

Abbreviated New Drug Application (Generic)

Brand name

SIMVASTATIN

Generic name

SIMVASTATIN

Active ingredients

SIMVASTATIN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD III

Manufacturer

XLCare Pharmaceuticals Inc.

First approval

2014-11-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown